October 2, 2026

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 36% Potential Upside in Healthcare

InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing opportunity for investors looking to tap into the healthcare sector, particularly in the niche of medical care facilities. With a market capitalization..

Investor Outlook: GH Research PLC (GHRS) Poised for 87.62% Upside with Promising Phase 2 Trials

GH Research PLC (NASDAQ: GHRS), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising clinical pipeline and substantial potential upside. Headquartered in Dublin, Ireland, the..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a 55% Upside in the Medical Devices Arena

Delcath Systems, Inc. (NASDAQ: DCTH) is drawing significant attention in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $534.71 million, this interventional oncology company..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Unpacking the 174% Potential Upside

Taysha Gene Therapies, Inc. (TSHA), a clinical-stage biotechnology company, has been the subject of significant investor interest due to its promising pipeline and compelling analyst ratings. Based in Dallas, Texas,..

Embecta Corp. (EMBC): Investor Outlook Amidst Potential Downside and Strategic Positioning

Embecta Corp. (NASDAQ: EMBC) finds itself at a pivotal moment as it navigates the challenging waters of the healthcare sector. With a market cap of $328.06 million, this Parsippany, New..

STAAR Surgical Company (STAA) Stock Analysis: Unveiling a 23.77% Potential Upside in the Healthcare Sector

Investors in the healthcare sector may find STAAR Surgical Company (NASDAQ: STAA) a compelling opportunity as it continues to make strides in the medical instruments and supplies industry. With a..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Contender with 33.68% Potential Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning player in the biotech sector, is capturing investor attention with its promising portfolio in the treatment of inflammatory diseases. As it continues to..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring the Growth Potential in Biotech Innovations

Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, has been attracting attention with its innovative approach to treating central nervous system (CNS) disorders. The company,..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating a Challenging Market with Solid Software Solutions

Simulations Plus, Inc. (NASDAQ: SLP) stands at the intersection of healthcare innovation and advanced technology, serving as a pivotal player in the Health Information Services industry. With a focus on..

Akebia Therapeutics (AKBA) Stock Analysis: Exploring a Potential 349% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands at a pivotal point in its journey as a specialty and generic drug manufacturer within the healthcare sector. Known for its focus on developing..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with 116.80% Potential Upside

Savara, Inc. (NASDAQ: SVRA) stands out in the healthcare sector as a promising biopharmaceutical company focused on rare respiratory diseases. With a market capitalization of $1.03 billion, Savara is making..

Beta Bionics, Inc. (BBNX): Investor Outlook Reveals 23.39% Potential Upside

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical device company, Beta Bionics focuses on enhancing..

Zymeworks Inc. (ZYME) Stock Analysis: Biotech Innovator with a 58% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising pipeline of biotherapeutics targeting cancer, inflammation, and autoimmune diseases. Based in..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 133.81% Potential Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the biotechnology sector as a company with promising momentum in cancer treatment development. Founded in 2018 and headquartered in New York City,..

Replimune Group, Inc. (REPL) Stock Analysis: Biotechnology Leader with Nearly 45% Upside Potential

Replimune Group, Inc. (NASDAQ: REPL) is a notable player in the biotechnology sector, specializing in cutting-edge oncolytic immunotherapies aimed at treating cancer. With a market capitalization of $1.27 billion, this..

CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Marvel with a Robust Revenue Growth

CareDx, Inc. (NASDAQ: CDNA), a significant player in the diagnostics and research sector within the healthcare industry, has been capturing investor attention with its impressive revenue growth and innovative solutions..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the -23.24% Potential Downside with Strong Revenue Growth

Cronos Group Inc. (NASDAQ: CRON), a prominent name in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, continues to be a focal point for investors interested..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a 533% Potential Upside in Biotech

LENZ Therapeutics, Inc. (LENZ) is making waves in the biotechnology sector, capturing the attention of investors with a staggering potential upside of 533.25%. As the company charts its path in..

SI-BONE, Inc. (SIBN) Stock Analysis: Unveiling a 35.8% Upside Potential with Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the medical devices industry, has garnered significant attention from investors, thanks to its potential upside of 35.8%. Specializing in innovative procedural solutions,..

Collegium Pharmaceutical, Inc. (COLL) Investor Outlook: A Promising 124% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the healthcare sector, is drawing significant attention from individual investors due to its substantial potential upside. The company is renowned for..

Search

Funds

October 2, 2026

Search

Funds

October 2, 2026

FTSE 100

Funds